Episode 186September 17, 2026
Episode 186: 29% of Explant Samples Had Bacterial DNA — Here's What That Means
September 17, 202639:48
Breast Implant IllnessExplant SurgeryResearchFat TransferCancer
In This Episode
Dr. Robert Whitfield reviews his study of 694 explant samples and its reported detection of bacterial DNA in 203 samples. He distinguishes bacterial DNA findings from evidence of active infection and discusses questions about biofilm and capsular contracture.
He explains the limits of next-generation sequencing results, including why they do not provide a diagnostic threshold, severity score, or treatment guide, and addresses questions about textured implants, BIA-ALCL, and fat transfer at explant.
Topics Covered
- Bacterial DNA and biofilm in explant samples
- Capsular contracture
- Next-generation sequencing study findings and limitations
- Textured implants and BIA-ALCL
- Fat transfer at explant
Related Resources
Ready to Talk About Your Situation?
Book a discovery call — this is where it starts. Dr. Whitfield will review your history and create a personalized plan.
Book a Discovery CallPatients from 40+ states and 15 countries · Virtual consultations available